We are live on ! Find out more
CYTHW

Cyclo Therapeutics, Inc. Warrant
CYTHW

Delisted

CYTHW was delisted on the 25th of March, 2025.

Back to rankings

1 hedge funds and large institutions have $3.29K invested in Cyclo Therapeutics, Inc. Warrant in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
1
Holders Change
+1
Holders Change %
–
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$2.83K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
1
Citadel Advisors
Florida
$3.29K +$2.83K +10,973 New

CYTHW Hedge Fund Activity: Q4 2023 in Review

1 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Cyclo Therapeutics, Inc. Warrant (CYTHW) for Q4 2023, worth a combined $3.29K.

Buyers outnumbered sellers: 1 fund opened new CYTHW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $2.83K.

  • 1 institutional investor held Cyclo Therapeutics, Inc. Warrant (CYTHW) as of Q4 2023, up from 0 in Q3 2023.
  • Funds reported $3.29K of Cyclo Therapeutics, Inc. Warrant stock for Q4 2023.
  • 1 fund opened new Cyclo Therapeutics, Inc. Warrant positions in Q4 2023 and 0 closed out, a net change of +1 holder.
  • The largest Cyclo Therapeutics, Inc. Warrant buyer in Q4 2023 was Citadel Advisors, an estimated $2.83K added.

Based on aggregated 13F filings for Q4 2023.